In the case of redundant probe with a fold change in the same direction only the probe set with the highest fold change was included in further analysis. pathways. The findings were also correlated with published data on human breast cancer. == Results == Metastatic canine mammary carcinomas had 1,011 significantly differentially expressed genes when compared to non-metastatic carcinomas. PM 102 Metastatic carcinomas had a significant up-regulation of genes associated with cell cycle regulation, matrix modulation, protein folding and proteasomal degradation whereas cell differentiation genes, growth factor pathway genes and regulators of actin organization were significantly down-regulated. Interestingly, 265 of the 1,011 differentially expressed canine genes are also related to human breast cancer and, vice PM 102 versa, parts of a human prognostic gene signature were identified in the expression profiles of the metastatic canine tumors. == Conclusions == Metastatic canine mammary carcinomas can be discriminated from non-metastatic carcinomas by their gene expression profiles. More than one third of the differentially expressed genes are also described of relevance for human breast cancer. Many of the differentially expressed genes are linked to functions and pathways which appear to be relevant for the induction and maintenance of metastatic progression and may represent new therapeutic targets. Furthermore, dogs are in some aspects suitable as a translational model for human PM 102 breast tumors in order to identify prognostic molecular signatures and potential therapeutic targets. == Background == Canine mammary tumor (CMT) is the most common cancer among female dogs and often becomes fatal due to the development of distant metastases [1-3]. Metastasis to the regional lymph node is an early step in metastasis and one TCF3 of the most important prognostic factors in the diagnosis of CMT, a criterion that is also valid for human breast cancer [4,5]. Lymph node metastases of CMT are usually followed by the development of distant metastases, mainly in the lung, ultimately leading to the death of the dog [6]. However, knowledge of the molecular PM 102 mechanisms contributing to lymph node and distant metastasis is still fragmentary. Despite several studies on this issue, significant metastasis-associated and predictable manifestation patterns of solitary genes have not been recognized in CMT as yet [7-9]. Global gene manifestation profiles that compare metastasizing versus non-metastasizing CMT are unavailable whereas several studies on human being breast cancer found out significant metastasis connected manifestation profiles. The second option studies identified several nonoverlapping manifestation signatures which are related to the development of lymph node and distant metastases and worse prognoses [10-13]. The available studies on global gene manifestation in CMT compared normal mammary gland, benign and malignant tumors with unfamiliar lymph node status and medical follow-up [14,15]. The authors reported the gene manifestation profiles of CMT include a gene manifestation signature associated with neoplastic transformation. Furthermore, assessment of canine and human being manifestation profiles disclosed an overlap of deregulated genes in human being and canine mammary tumors [15]. Generally, medical and molecular features of human being and canine carry a likeness in several elements. Both malignancies are the most common malignancy of the female, lymph node metastases show a poor prognosis, the hormonal status influences the development of CMT and estrogen receptor (ER), progesterone receptor (PR) and ERBB2 manifestation patterns do influence the overall survival rate [1,16-18]. The aim of this study was the recognition of gene manifestation signatures in main CMT that are associated with early lymph node metastasis. Global mRNA manifestation profiles from metastatic versus non-metastatic CMT instances were compared and differentially indicated genes were analyzed for his or her function and their part in pathway activation. Moreover, mining in published literature exposed interesting overlapping features when compared to data derived from gene manifestation profiles of metastatic human being breast carcinomas. == Methods == == Cells samples == Thirteen simple mammary carcinomas with invasive growth and lymph node metastases at the time of tumor resection PM 102 and 14 simple carcinomas without lymph node metastases were included in the study (Table1). Complex carcinomas were excluded from the study to avoid variations in gene manifestation levels due to variations in mesenchymal/epithelial percentage in the different tissues. None of the individuals had a history of progestin treatment or radiographically detectable pulmonary metastases at the time of tumor resection. Distant metastases as the cause of death were identified postoperatively by radiographic detection of metastases (nos. 1-11) or necropsy (nos. 12 and 13). Selection criteria for carcinomas without lymph node metastases included an invasive growth, a negative lymph node status, a histological grade III and a minimal tumor diameter above the average of the lymph node positive tumors.